Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Federica Catalanotti

A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal

scientific article published on 15 February 2009

A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.

scientific article published on 8 May 2015

Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy

scientific article published on 12 July 2017

Direct effects of polymyxin B on human dendritic cells maturation. The role of IkappaB-alpha/NF-kappaB and ERK1/2 pathways and adhesion

scientific article published on 25 January 2005

Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development

scientific article

GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas

scientific article published on 08 December 2018

Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery.

scientific article

HMGB1 is an endogenous immune adjuvant released by necrotic cells

scientific article

Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma

scientific article published on 31 October 2018

Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma

scientific article published on 7 March 2018

Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds

scientific article published on 06 June 2018

MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance

scientific article published on 28 February 2013

PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma

scientific article published on 23 June 2017

Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.

scientific article published on 26 February 2013

Reply

Will Hsp90 Inhibitors Prove Effective in BRAF-Mutant Melanomas? ⬇️

scientific article published on March 22, 2012

Paulina is supported by:

About Paulina

Help